261 related articles for article (PubMed ID: 19318661)
1. Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients.
Miano TA; Reichert MG; Houle TT; MacGregor DA; Kincaid EH; Bowton DL
Chest; 2009 Aug; 136(2):440-447. PubMed ID: 19318661
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
van Zyl J; van Rensburg C; Vieweg W; Fischer R
Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
[TBL] [Abstract][Full Text] [Related]
3. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials.
Messori A; Trippoli S; Vaiani M; Gorini M; Corrado A
BMJ; 2000 Nov; 321(7269):1103-6. PubMed ID: 11061729
[TBL] [Abstract][Full Text] [Related]
4. Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis.
Alhazzani W; Guyatt G; Alshahrani M; Deane AM; Marshall JC; Hall R; Muscedere J; English SW; Lauzier F; Thabane L; Arabi YM; Karachi T; Rochwerg B; Finfer S; Daneman N; Alshamsi F; Zytaruk N; Heel-Ansdell D; Cook D;
Crit Care Med; 2017 Jul; 45(7):1121-1129. PubMed ID: 28459708
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based analysis: postoperative gastric bleeding: etiology and prevention.
Hiramoto JS; Terdiman JP; Norton JA
Surg Oncol; 2003 Jul; 12(1):9-19. PubMed ID: 12689666
[TBL] [Abstract][Full Text] [Related]
6. Pantoprazole or Placebo for Stress Ulcer Prophylaxis (POP-UP): Randomized Double-Blind Exploratory Study.
Selvanderan SP; Summers MJ; Finnis ME; Plummer MP; Ali Abdelhamid Y; Anderson MB; Chapman MJ; Rayner CK; Deane AM
Crit Care Med; 2016 Oct; 44(10):1842-50. PubMed ID: 27635481
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of stress ulcer prophylaxis in septic patients: a retrospective cohort study based on large database].
Huang M; Kuang L; Han M; Han W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):641-647. PubMed ID: 34296679
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of nosocomial pneumonia in mechanically ventilated trauma patients: a comparison of sucralfate and ranitidine.
Pickworth KK; Falcone RE; Hoogeboom JE; Santanello SA
Crit Care Med; 1993 Dec; 21(12):1856-62. PubMed ID: 8252890
[TBL] [Abstract][Full Text] [Related]
9. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.
Cook D; Guyatt G; Marshall J; Leasa D; Fuller H; Hall R; Peters S; Rutledge F; Griffith L; McLellan A; Wood G; Kirby A
N Engl J Med; 1998 Mar; 338(12):791-7. PubMed ID: 9504939
[TBL] [Abstract][Full Text] [Related]
10. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers.
Grindlinger GA; Cairo SB; Duperre CB
J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
12. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients.
Ro Y; Eun CS; Kim HS; Kim JY; Byun YJ; Yoo KS; Han DS
Gut Liver; 2016 Jul; 10(4):581-6. PubMed ID: 27021503
[TBL] [Abstract][Full Text] [Related]
13. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
[TBL] [Abstract][Full Text] [Related]
14. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
Tofil NM; Benner KW; Fuller MP; Winkler MK
J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
[TBL] [Abstract][Full Text] [Related]
15. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
[TBL] [Abstract][Full Text] [Related]
16. Stress ulcer prophylaxis in patients on ventilator.
Darlong V; Jayalakhsmi TS; Kaul HL; Tandon R
Trop Gastroenterol; 2003; 24(3):124-8. PubMed ID: 14978984
[TBL] [Abstract][Full Text] [Related]
17. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial.
Apte NM; Karnad DR; Medhekar TP; Tilve GH; Morye S; Bhave GG
Crit Care Med; 1992 May; 20(5):590-3. PubMed ID: 1572183
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors do not increase the risk of acute rejection.
van Boekel GA; Kerkhofs CH; van de Logt F; Hilbrands LB
Neth J Med; 2014 Feb; 72(2):86-90. PubMed ID: 24659591
[TBL] [Abstract][Full Text] [Related]
19. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
20. Incidence of infectious complications associated with the use of histamine2-receptor antagonists in critically ill trauma patients.
O'Keefe GE; Gentilello LM; Maier RV
Ann Surg; 1998 Jan; 227(1):120-5. PubMed ID: 9445119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]